1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 2: Summary of inconclusive results of USFNA and USCNB
Total Benign Malignant FU loss
USFNA 30 
    Inadequate specimen 14 8 1 5
    Others^{^a} 16 11 5 0
USCNB 10 
    Inadequate specimen 1 0 1 0
    Others^{^a} 9 3 4 2
Note:—FU indicates follow-up.
↵a “Others” include inconclusive results for differential diagnoses between benign and malignant salivary gland tumors.
	Total	Benign	Malignant	FU loss
USFNA	30
Inadequate specimen	14	8	1	5
Others^{^a}	16	11	5	0
USCNB	10
Inadequate specimen	1	0	1	0
Others^{^a}	9	3	4	2